Global pharma leader Lupin has taken a major step forward in the U.S. biosimilar market with a new exclusive licensing agreement for Armlupeg (pegfilgrastim-unne). The company announced today that it has partnered with Valorum Biologics, a...
Pharma company Corona Remedies, supported by private equity firm ChrysCapital, has set a price range of Rs 1,008-1,062 per share for its forthcoming Initial Public Offering (IPO), which values the firm at approximately Rs 6,500 crore
AptarGroup, a worldwide leader in dosing, dispensing, and protection technologies for drugs and consumer products, has revealed the purchase of Sommaplast, a Brazil-based company that specializes in oral dosing pharmaceutical packaging solutions
Tata 1mg and OneBanc have forged a strategic partnership aimed at revolutionizing India’s corporate healthcare sector, a market valued at over Rs. 12,000 crore annually across diagnostics, outpatient services, and preventive wellness
.png "Cipla Steps Into Regenerative Medicine With Ciplostem Knee OA Therapy")
Ciplostem, launched today by Cipla in partnership with Stempeutics Research, signals a strong move into orthobiologic medicine. The new MSC therapy enters the market as India faces a fast-growing burden of knee osteoarthritis, now affecting more...
.png "Novo Nordisk Brings Ozempic to India to Challenge Mounjaro's Lead")
Danish drugmaker Novo Nordisk is preparing to launch Ozempic in India this month, marking a major move in a market already battling rising diabetes and obesity. The arrival of the blockbuster drug comes at a time when India has the world’s...
On World AIDS Day, the World Health Organization called for urgent action to expand access to new HIV prevention tools, warning that deep cuts to foreign aid have disrupted essential services in many countries. The spotlight is on lenacapavir...
GSK plc will showcase new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, scheduled from 6–9 December, underlining its commitment to improving outcomes for patients with difficult-to
The World Health Organization (WHO) has issued its first-ever guideline on using Glucagon-Like Peptide-1 (GLP-1) therapies to treat obesity, recognizing it as a chronic and recurring condition that now affects more than 1 billion people worldwide
AstraZeneca’s baxdrostat has taken a major step forward today as the US FDA accepted its New Drug Application (NDA) for Priority Review. The drug is aimed at adults with hard-to-control hypertension who need added help even after multiple blood...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")